PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.

ABSTRACT:

SUBMITTER: Azad A 

PROVIDER: S-EPMC11758155 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature